VA Study: Type 2 Diabetes Patients Quitting GLP-1s Face Reversed Weight Loss and Higher Heart Risks
A VA study found type 2 diabetes patients stopping GLP-1 drugs regained weight and faced a 22% rise in cardiovascular risks.
Read MoreALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
A VA study found type 2 diabetes patients stopping GLP-1 drugs regained weight and faced a 22% rise in cardiovascular risks.
Read More